Patients who may particularly benefit from the oral option include: Those with needle concerns: While modern GLP-1 injections use very small needles, some patients have significant needle phobia that prevents them from starting treatment Patients seeking a less medical approach: Some individuals prefer the familiarity of taking a daily pill over self-injecting Weight maintenance candidates: Emerging research suggests oral GLP-1s may be effective for maintaining weight loss after achieving goals on injectable medications Those with access challenges: Pills dont require refrigeration and may be easier to travel with Important Considerations Before Switching or Starting The Wegovy pill will be available in January 2026, with the starting 1.5mg dose priced at $149 per month for cash-paying patients
Pancreatitisinflammation of the pancreaspresents as severe upper abdominal pain, often radiating to the back, along with nausea and vomiting
Verma S, McGuire DK, Bain SC, Bhatt DL, Leiter LA, Mazer CD et al (2020) Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
See attached flyer for more information
Anything that does cross the intestinal wall enters the portal vein and goes directly to the liver before reaching systemic circulation